New drug trial aims to tame deadly protein clogging chinese hearts
NCT ID NCT06194825
Summary
This study is testing if a drug called eplontersen can help control a serious heart disease caused by abnormal protein buildup. It involves 64 Chinese adults with this condition. For the first 24 weeks, some will receive the drug and others a placebo, followed by a longer period where all participants can receive the active treatment to check its long-term safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100029, China
-
Research Site
Beijing, 100034, China
-
Research Site
Beijing, 100037, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 100730, China
-
Research Site
Changsha, 410008, China
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, 430033, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chengdu, 610072, China
-
Research Site
Chongqing, 400010, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Guangzhou, 510062, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310014, China
-
Research Site
Hangzhou, 310052, China
-
Research Site
Ha’erbin, 150001, China
-
Research Site
Jinan, 250001, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Suzhou, 215006, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Wuhan, 430060, China
-
Research Site
Xi'an, 710061, China
Conditions
Explore the condition pages connected to this study.